Gene · 780
Papers2,465
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 2,465
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Epigallocatechin-3-Gallate Prevents the Acquisition of a Cancer Stem Cell Phenotype in Ovarian Cancer Tumorspheres through the Inhibition of Src/JAK/STAT3 Signaling. | Biomedicines | 2023 | 37189618 | PubTator, text mining | PubMed |
| Cancer-Associated Fibroblasts and Extracellular Matrix: Therapeutical Strategies for Modulating the Cholangiocarcinoma Microenvironment. | Curr Oncol | 2023 | 37185432 | PubTator, text mining | PubMed |
| Prediction of liver cancer prognosis based on immune cell marker genes. | Front Immunol | 2023 | 37180166 | PubTator, text mining | PubMed |
| A Descriptive Whole-Genome Transcriptomics Study in a Stem Cell-Based Tool Predicts Multiple Tissue-Specific Beneficial Potential and Molecular Targets of Carnosic Acid. | Int J Mol Sci | 2023 | 37175790 | PubTator, text mining | PubMed |
| BRAF V600-Mutated Metastatic Melanoma and Targeted Therapy Resistance: An Update of the Current Knowledge. | Cancers (Basel) | 2023 | 37174072 | PubTator, text mining | PubMed |
| Exploring the Advantages of Quantum Generative Adversarial Networks in Generative Chemistry. | J Chem Inf Model | 2023 | 37171372 | PubTator, text mining | PubMed |
| Proteomic characteristics reveal the signatures and the risks of T1 colorectal cancer metastasis to lymph nodes. | Elife | 2023 | 37158593 | PubTator, text mining | PubMed |
| The PLOD2/succinate axis regulates the epithelial-mesenchymal plasticity and cancer cell stemness. | Proc Natl Acad Sci U S A | 2023 | 37155842 | PubTator, text mining | PubMed |
| Discoidin domain receptor 1 as a promising biomarker for high-grade gliomas. | J Cancer Res Ther | 2023 | 37147958 | PubTator, text mining | PubMed |
| Investigating the relationship between depression and breast cancer: observational and genetic analyses. | BMC Med | 2023 | 37143087 | PubTator, text mining | PubMed |
| Toxicities associated with immune checkpoint inhibitors: a systematic study. | Int J Surg | 2023 | 37132038 | PubTator, text mining | PubMed |
| Recombinant humanized collagen remodels endometrial immune microenvironment of chronic endometritis through macrophage immunomodulation. | Regen Biomater | 2023 | 37122820 | PubTator, text mining | PubMed |
| Collagen I-DDR1 signaling promotes hepatocellular carcinoma cell stemness via Hippo signaling repression. | Cell Death Differ | 2023 | 37117273 | PubTator, text mining | PubMed |
| Application of Computing as a High-Practicability and -Efficiency Auxiliary Tool in Nanodrugs Discovery. | Pharmaceutics | 2023 | 37111551 | PubTator, text mining | PubMed |
| Application of Artificial Intelligence in the Diagnosis, Treatment, and Prognostic Evaluation of Mediastinal Malignant Tumors. | J Clin Med | 2023 | 37109155 | PubTator, text mining | PubMed |
| MicroRNA Expression Signatures in Clear Cell Renal Cell Carcinoma: High-Throughput Searching for Key miRNA Markers in Patients from the Volga-Ural Region of Eurasian Continent. | Int J Mol Sci | 2023 | 37108073 | PubTator, text mining | PubMed |
| Hypoxia disrupt tight junctions and promote metastasis of oral squamous cell carcinoma via loss of par3. | Cancer Cell Int | 2023 | 37095487 | PubTator, text mining | PubMed |
| Multi-omics analysis of the Indian ovarian cancer cohort revealed histotype-specific mutation and gene expression patterns. | Front Genet | 2023 | 37091785 | PubTator, text mining | PubMed |
| Adaptive c-Met-PLXDC2 Signaling Axis Mediates Cancer Stem Cell Plasticity to Confer Radioresistance-associated Aggressiveness in Head and Neck Cancer. | Cancer Res Commun | 2023 | 37089864 | PubTator, text mining | PubMed |
| Deciphering STAT3 signaling potential in hepatocellular carcinoma: tumorigenesis, treatment resistance, and pharmacological significance. | Cell Mol Biol Lett | 2023 | 37085753 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/780/papers?page=19